Lung Disease Summit 2025
2025 Advanced Respiratory Disease and Lung Transplant Summit
September 18, 2025
·
Vivian and Seymour Milstein Family Heart Center
Program Overview
The summit aims to provide a comprehensive platform for healthcare professionals, researchers, and specialists to discuss recent developments in the field of advanced lung disease, including state-of-the-art therapies for chronic obstructive pulmonary disease (COPD), the latest diagnostic and treatment approaches to interstitial lung disease (ILD), novel treatments for cystic fibrosis (CF) and non-CF bronchiectasis, lung cancer, asthma, and multi-modality management of pulmonary hypertension (PH). We will highlight the importance of multi-disciplinary care of these complex patients with medical co-morbidities, including advanced therapies for lung disease (ECMO, LVRS, BLVR, atrial septostomy, Potts shunt) and the key therapeutic role of lung transplantation. By highlighting the latest research and technological advancements, the program seeks to enhance understanding and collaboration within the medical community. We will employ interactive presentations, including case discussions and a mock multi-disciplinary team meeting, with audience participation through audience response elements embedded into the lectures.
Learning Objectives:
- Understand evidence-based diagnostic approaches and interventions for the management of patients with various lung diseases including ILD, COPD, asthma, CF and non-CF bronchiectasis, PH, and lung cancer.
- Identify appropriate indications for referral and evaluation for advanced therapies such as ECMO, LVRS, BLVR and lung transplantation among patients with advanced lung diseases.
- Discuss the pharmacologic, surgical and other treatment options for patients with advanced lung diseases.
Target Audience
This program has been designed for primary care physicians, pulmonologists, radiologists, thoracic surgeons, respiratory therapists, nurses, physician assistants, nurse practitioners, healthcare researchers, scientists, and other medical professionals involved in the care of patients with advanced lung disease.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Columbia University Department of Surgery and Amedco LLC. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
Amedco LLC designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians Assistants
PAs may claim a maximum of 7.50 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioners
The American Academy of Nurse Practitioners Certification Board (AANPCB) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Maximum 7.50 hours.
American Board of Internal Medicine (ABIM) MOC
Successful completion of this CME
activity, which includes participation in the evaluation component, enables the
participant to earn up to 7.50 Medical Knowledge MOC points in the American
Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting
ABIM MOC credit.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed above, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Refund Policy
Registration is limited and will be handled on a first-come, first-served basis. Telephone registrations/cancellations/refunds cannot be accepted.
Method of Participation
You will receive a confirmation email before the event with instructions for joining via Zoom and attending the Summit In-person instructions.
Tickets
In-person Registration Options
MD, DO, PhD
175.00 USD
RN, NP, PA
150.00 USD
Fellows, Residents, Students, VIP: FREE
0.00 USD
Virtual Registration Options
MD, DO, PhD
150.00 USD
RN, NP, PA
100.00 USD
Fellows, Residents & Students: FREE
0.00 USD
Agenda
Thursday, September 18
7:00 AM
7:00 AM
Event Start
7:00 AM - 8:00 AM
7:00 AM - 8:00 AM
Registration | Breakfast | Exhibit Hall
8:00 AM - 8:15 AM
8:00 AM - 8:15 AM
Welcoming Remarks
Anna J. Podolanczuk, MD, MS
NewYork-Presbyterian/Weill Cornell Medical Center
8:15 AM
8:15 AM
Session One
8:15 AM - 8:45 AM
8:15 AM - 8:45 AM
State of the Art Therapy for Advanced COPD and Emphysema
Jamuna Krishnan, MD
Weill Cornell Medicine
8:45 AM - 9:15 AM
8:45 AM - 9:15 AM
Novel Approaches to Severe Asthma
Emily DiMango, MD
Columbia University Irving Medical Center
9:15 AM - 9:45 AM
9:15 AM - 9:45 AM
New Developments in Bronchiectasis
Claire Keating, MD
Columbia University Irving Medical Center
9:45 AM - 10:15 AM
9:45 AM - 10:15 AM
Current Approaches to Diagnosis and Treatment of Lung Cancer
Nasser Altorki, MD,
Weill Cornell Medicine
10:15 AM - 10:30 AM
10:15 AM - 10:30 AM
Morning Break | Exhibit Hall
10:30 AM
10:30 AM
Session Two
10:30 AM - 11:00 AM
10:30 AM - 11:00 AM
State of the Art in Management of ILD
Kerri Aronson, MD,
Weill Cornell Medicine
11:00 AM - 12:00 PM
11:00 AM - 12:00 PM
Moderator: Anna Podolanczuk, MD, MS
Weill Cornell Medicine
12:00 PM - 1:00 PM
12:00 PM - 1:00 PM
Lunch | Exhibit Hall
1:00 PM
1:00 PM
Session Three
1:00 PM - 1:30 PM
1:00 PM - 1:30 PM
Evaluation and Management of Pulmonary Hypertension in Advanced Lung Disease
Jennifer Haythe, MD
Columbia University Irving Medical Center
1:30 PM - 2:00 PM
1:30 PM - 2:00 PM
Frailty: Role of Pulmonary Rehabilitation
Aimee Layton, MD
Columbia University Irving Medical Center
2:00 PM - 2:45 PM
2:00 PM - 2:45 PM
Case Discussion: Diagnostic Dilemmas & Treatment Decisions in Advanced Lung Disease
Case 1: PCD
Kaitlyn Seitz, MD, Weill Cornell Medicine
Case 2: ILD with lung cancer
Claire McGroder, MD, Columbia University
Case 3: CTEPH
Estefania Oliveros Soles, MD Columbia University
2:45 PM - 3:00 PM
2:45 PM - 3:00 PM
Afternoon Break | Exhibit Hall
3:00 PM
3:00 PM
Session Four
3:00 PM - 3:30 PM
3:00 PM - 3:30 PM
Approach to Extracorporeal Membrane Oxygenation (ECMO) in the Management of Patients with Advanced Lung Disease
Cara Agerstrand, MD
Columbia University Irving Medical Center
3:30 PM - 4:00 PM
3:30 PM - 4:00 PM
When All Else Fails: The Role of Lung Transplantation
Luke Benvenuto, MD, MPH
Columbia University Irving Medical Center
4:00 PM - 4:45 PM
4:00 PM - 4:45 PM
Moderator: Selim Arcasoy, MD, MPH
Columbia University Irving Medical Center
4:45 PM - 5:00 PM
4:45 PM - 5:00 PM
Closing Remarks | Submissions of Evaluations
Selim M. Arcasoy, MD, MPH
NewYork-Presbyterian/Columbia University Irving Medical Center
5:00 PM
5:00 PM
Event End